Venous Thromboembolism Diagnosis and Management

Venous Thromboembolism Diagnosis and Management is a research topic within Internal Medicine. Science Explorer counts 74k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the prevention, diagnosis, and treatment of venous thromboembolism (VTE), including pulmonary embolism and deep vein thrombosis. It covers various aspects such as antithrombotic therapy, risk factors, prophylaxis, and management in patients with cancer. The cluster also discusses the development of clinical practice guidelines for VTE.

Venous Thromboembolism
Antithrombotic Therapy
Pulmonary Embolism
Deep Vein Thrombosis
Cancer-Associated Thrombosis
Prophylaxis
Risk Factors
Diagnosis
Treatment
Clinical Practice Guidelines

Research works: 74k
In the world top 10%: 7.4k
Top-10% rate: 9.9%
Growth, 2018-21 → 2022-25: +0%
Largest producer: United States

Venous Thromboembolism Diagnosis and Management

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Venous Thromboembolism Diagnosis and Management research?

By volume, the United States and China publish the most (4.2k and 1.8k works in 2022-now).

By volume, 2022-now

1 United States 4.2k works
2 China 1.8k works
3 United Kingdom 611 works
4 Japan 598 works
5 Italy 530 works
6 India 508 works
7 Germany 498 works
8 Spain 432 works
9 Türkiye 432 works
10 France 409 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States4,152 · 41.7%China1,795 · 18.0%United Kingdom611 · 6.1%Japan598 · 6.0%6 others listed2,808 · 28.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Venous Thromboembolism Diagnosis and Management research?

By volume in 2022-now, Harvard University publishes the most Venous Thromboembolism Diagnosis and Management research, followed by Mayo Clinic and Capital Medical University.

By volume, 2022-now

1 Harvard UniversityUnited States 183 works
2 Mayo ClinicUnited States 93 works
3 Capital Medical UniversityChina 83 works
4 University of North Carolina at Chapel HillUnited States 72 works
5 University of OttawaCanada 64 works
6 Sichuan UniversityChina 61 works
7 Cleveland ClinicUnited States 58 works
8 Yale UniversityUnited States 58 works
9 University of MichiganUnited States 56 works
10 New York UniversityUnited States 55 works

Who are the leading researchers in Venous Thromboembolism Diagnosis and Management?

The most-cited researchers publishing on Venous Thromboembolism Diagnosis and Management include David Moher, Douglas G. Altman and George Davey Smith.

1 David Moher Canada 898k citations
2 Douglas G. Altman United Kingdom 862k citations
3 George Davey Smith United Kingdom 435k citations
4 Mark J. Daly United States 403k citations
5 Julian P. T. Higgins United Kingdom 390k citations
6 John J.V. McMurray United Kingdom 349k citations
7 Hermann Brenner Germany 343k citations
8 Cyrus Cooper United Kingdom 342k citations
9 Emelia J. Benjamin United States 341k citations
10 Valery L. Feigin New Zealand 341k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Venous Thromboembolism Diagnosis and Management?

The most cited paper in Venous Thromboembolism Diagnosis and Management is "Correspondence - Tranexamic acid for traumatic brain injury" (Marina Romanello et al., 2005), with 11,912 citations. Next come "Dabigatran versus Warfarin in Patients with Atrial Fibrillation" (11,272) and "Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach" (6,816).

Most cited papers
#	Paper	Released	Citations
1	Correspondence - Tranexamic acid for traumatic brain injury Marina Romanello et al. · London School of Economics and Political Science Theses Online (London School of Economics and Political Science) Open access	2005	11,912
2	Dabigatran versus Warfarin in Patients with Atrial Fibrillation Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine Open access	30 Aug 2009	11,272
3	Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach Gregory Y.H. Lip, Robby Nieuwlaat, Ron Pisters et al. · CHEST Journal Open access	18 Sep 2009	6,816
4	Antithrombotic Therapy for VTE Disease Clive Kearon, Elie A. Akl, Anthony James Comerota et al. · CHEST Journal Open access	Feb 2012	6,164
5	Prevention of Venous Thromboembolism William H Geerts, Graham Frederick Pineo, John A. Heit et al. · CHEST Journal	Sep 2004	5,923

All 96 most cited papers, with filters and sorting

Where is Venous Thromboembolism Diagnosis and Management research done?

The largest centres of Venous Thromboembolism Diagnosis and Management research in 2022-now are Beijing (China), New York (United States), London (United Kingdom) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Maywood and New Hyde Park.

Largest cities, 2022-now

1 BeijingChina 272 works
2 New YorkUnited States 220 works
3 LondonUnited Kingdom 187 works
4 BostonUnited States 176 works
5 MoscowRussia 164 works
6 ParisFrance 148 works
7 MadridSpain 145 works
8 PhiladelphiaUnited States 144 works
9 TokyoJapan 129 works
10 IstanbulTürkiye 120 works

Where it is the local speciality

MaywoodUS · 20.9 works22×
New Hyde ParkUS · 21.3 works11×

← less than its size predicts1×more →

Location quotient: how much more of its research is in Venous Thromboembolism Diagnosis and Management than the world average.

See Venous Thromboembolism Diagnosis and Management on the map

Where is the best place to study Venous Thromboembolism Diagnosis and Management?

Among universities, judged by research, Harvard University, University of Ottawa and Medical University of Vienna score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged

40%

Specialisationhow much of its work is in this field, counted up to 10× the world share

10%

Sizeits output in this field, on a log scale

30%

Growthoutput growth, counted from -20% to +20%

10%

Internationalshare of its work with a co-author abroad

10%

Each slider sets a weight; the share it gets of the score is beside it.

#	University	Score	Top 10%	Specialisation	Works	Growth
1	Harvard UniversityUnited States	77.1	16.8%	4.6×	183	-0.2%
2	University of OttawaCanada	74.7	24.2%	7.8×	64	-7.2%
3	Medical University of ViennaAustria	68.8	16.8%	8.5×	34	+12.1%
4	Leiden UniversityNetherlands	68.2	19.9%	5.5×	37	-17.6%
5	Johannes Gutenberg University MainzGermany	64.4	23.8%	8.1×	38	-11.7%
6	Erasmus University RotterdamNetherlands	64.3	18.9%	3.5×	23	+20.7%
7	Maastricht UniversityNetherlands	63.6	22.1%	4.5×	22	-17.0%
8	New York UniversityUnited States	62.9	14.4%	3.9×	54	+26.1%
9	McMaster UniversityCanada	61.7	15.4%	6.2×	45	-38.5%
10	University of BernSwitzerland	59.9	21.4%	4.2×	29	-12.6%
11	Johns Hopkins UniversityUnited States	59.5	17.8%	2.4×	45	-2.4%
12	Radboud University NijmegenNetherlands	59.2	20.4%	2.1×	16	+19.1%
13	Sichuan UniversityChina	59.1	13.2%	2.2×	61	+38.2%
14	University of GenevaSwitzerland	59.1	23.7%	2.3×	12	+4.9%
15	Yale UniversityUnited States	58.0	13.5%	4.3×	58	+11.3%
16	University of VermontUnited States	57.9	17.9%	6.8×	16	+12.3%
17	University of TorontoCanada	57.6	12.7%	2.0×	50	-0.8%
18	Heidelberg UniversityGermany	57.5	20.2%	3.0×	29	+7.8%
19	Utrecht UniversityNetherlands	57.2	17.9%	1.7×	16	+20.1%
20	Wenzhou Medical UniversityChina	57.1	17.0%	4.6×	29	+77.3%
21	University of ZurichSwitzerland	56.3	16.6%	2.9×	25	+12.5%
22	University of LiverpoolUnited Kingdom	55.5	19.4%	3.7×	26	-3.9%
23	University of FlorenceItaly	55.2	22.7%	1.9×	14	+13.6%
24	University of AmsterdamNetherlands	54.3	24.6%	1.6×	12	-18.4%
25	Royal College of Surgeons in IrelandIreland	54.3	16.2%	6.6×	8	+15.8%
26	Duke UniversityUnited States	53.6	10.1%	2.8×	29	+30.4%
27	Chongqing Medical UniversityChina	53.3	14.1%	5.3×	37	+49.5%
28	University of BirminghamUnited Kingdom	53.0	23.1%	1.9×	15	-7.4%
29	Karolinska InstitutetSweden	52.7	19.3%	3.1×	22	-24.4%
30	Università Cattolica del Sacro CuoreItaly	52.7	18.2%	3.5×	19	+13.8%
31	Boston UniversityUnited States	52.7	19.1%	1.9×	11	+4.1%
32	University of Electronic Science and Technology of ChinaChina	52.7	23.4%	0.6×	9	+541.1%
33	Hebei Medical UniversityChina	52.4	14.6%	7.2×	30	+73.0%
34	Victor Babeș University of Medicine and Pharmacy TimișoaraRomania	52.4	21.8%	8.9×	10	+108.3%
35	Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina	51.9	15.5%	3.5×	46	-2.3%
36	Temple UniversityUnited States	51.8	6.0%	12.0×	49	+49.4%
37	University of MichiganUnited States	51.6	11.4%	2.9×	56	-13.3%
38	University of GothenburgSweden	51.6	18.0%	1.9×	11	+67.4%
39	Capital Medical UniversityChina	51.4	11.0%	6.3×	83	-8.5%
40	Guangxi Medical UniversityChina	51.4	18.5%	5.0×	16	+93.2%
41	New York Medical CollegeUnited States	50.9	7.3%	13.3×	38	+21.6%
42	University of InsubriaItaly	48.4	21.8%	7.3×	9	-27.8%
43	University of North Carolina at Chapel HillUnited States	48.3	7.8%	3.3×	72	-12.9%
44	Imperial College LondonUnited Kingdom	47.1	12.1%	2.5×	32	-17.3%
45	University of GroningenNetherlands	45.9	20.7%	1.2×	10	-30.8%
46	Pirogov Russian National Research Medical UniversityRussia	43.7	4.7%	16.7×	36	+31.6%
47	King Saud bin Abdulaziz University for Health SciencesSaudi Arabia	43.6	8.9%	9.4×	11	+32.7%
48	Loyola University ChicagoUnited States	42.6	6.7%	13.6×	33	+3.5%
49	University of Hong KongChina	41.6	8.0%	1.0×	12	+158.2%
50	Chinese University of Hong KongChina	34.4	8.1%	0.9×	8	+33.7%
51	King Saud UniversitySaudi Arabia	34.2	9.2%	0.8×	10	+17.9%
52	Toho UniversityJapan	33.5	6.0%	8.7×	10	+80.8%
53	Ryazan State Medical University named after Academician I.P. PavlovRussia	33.0	6.3%	25.3×	12	+70.1%
54	King Abdulaziz UniversitySaudi Arabia	30.9	5.6%	1.2×	8	+193.2%
55	National University of SingaporeSingapore	27.6	10.6%	0.7×	10	-15.9%
56	Nicolae Testemițanu State University of Medicine and PharmacyMoldova	23.3	0.4%	13.2×	8	+217.1%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Venous Thromboembolism Diagnosis and Management, country by country

Is Venous Thromboembolism Diagnosis and Management research growing?

Output in 2022-2025 was 0% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Venous Thromboembolism Diagnosis and Management.

grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Venous Thromboembolism Diagnosis and Management as a percentage of every work published that year, 0.060% in 2024.

Fractional works of Venous Thromboembolism Diagnosis and Management over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Venous Thromboembolism Diagnosis and Management. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.

Which countries lead Venous Thromboembolism Diagnosis and Management research?

By volume, 2022-now

How concentrated that is

Which institutions lead Venous Thromboembolism Diagnosis and Management research?

By volume, 2022-now

Who are the leading researchers in Venous Thromboembolism Diagnosis and Management?

What are the most cited papers in Venous Thromboembolism Diagnosis and Management?

Where is Venous Thromboembolism Diagnosis and Management research done?

Largest cities, 2022-now

Where it is the local speciality

Where is the best place to study Venous Thromboembolism Diagnosis and Management?

Is Venous Thromboembolism Diagnosis and Management research growing?

Its share of all research

How much of it reaches the world top 10%

Which topics inside it are moving

Related research

Discussion